Showing results (491-500 of 2,341) with videos related to

Sort By:
Pageof 235
Applied Immunohistochemistry & Molecular Morphology : AIMM|June 6, 2008
Uroplakin is not a reliable immunohistochemical marker for malignant mesothelioma of the pleuraKelly J Butnor, Nelson G Ordonez
Applied Immunohistochemistry & Molecular Morphology : AIMM|May 9, 2014
The utility of BRAFV600E mutation-specific antibody for colon cancers with microsatellite instabilityStephanie Nolan, Thomas Arnason, Arik Drucker, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|May 10, 2014
Multiplex quantitative measurement of mRNAs from fixed tissue microarray sectionsMichael Armani, Michael Tangrea, Brian Yang, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|March 30, 2019
Combined Plasmatic and Tissue Approach to Membranous Nephropathy-Proposal of a Diagnostic Algorithm Including Immunogold Labelling: Changing the Paradigm of a Serum-based ApproachVincenzo L'Imperio, Federico G Pieruzzi, Renato A Sinico, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|March 18, 2021
Clinical Application of Chromosome Microarray Analysis in the Diagnosis of Lipomatous TumorsJianming Pei, Douglas B Flieder, Jacqueline N Talarchek, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|June 5, 2014
Reactive lymphoid hyperplasia of the terminal ileum: a benign (lymphoma-like) condition that may harbor aberrant immunohistochemical patterns or clonal immunoglobulin heavy chain gene rearrangementsAmirkaveh Mojtahed, Reetesh K Pai, Matthew W Anderson, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|June 5, 2014
C4d staining as immunohistochemical marker in inflammatory myopathiesPeter Pytel
Applied Immunohistochemistry & Molecular Morphology : AIMM|January 23, 2015
Uroplakin II (UPII), GATA3, and p40 are Highly Sensitive Markers for the Differential Diagnosis of Invasive Urothelial CarcinomaLaura L Hoang, David Tacha, Ryan E Bremer, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|July 4, 2014
Well-differentiated thyroid cancer with a minor poorly differentiated component: clonal heterogeneity through the prognostic role of CXCR4 and BRAF analysisEsther D Rossi, Maurizio Martini, Sara Capodimonti, et al.
Pageof 235